← Leaderboards
Corey Bolton
Vanderbilt University Medical Center
$438,974
Attributed
$438,974
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $185K · FY2022–25$200K$150K$100K$50K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$438,974 · 2
By mechanism
K23$369,300 · 1
F32$69,674 · 1
Top collaborators
No co-investigators on record.
Most similar at Vanderbilt University Medical Center
Same institution · by research overlap
- John C Gore$64,324,679
- Christopher S. Williams$20,507,087
- Timothy R Sterling$15,317,436
- Bruno De Bezerril Andrade$7,269,169
- Angela L. Jefferson$48,680,773
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposScientistAutopsyDementiaPublic HealthPlasmaClinical ManagementCareerCohortCollaborationsMemoryInternationalMentorsMentorshipFutureAgingResourcesBloodBiological MarkersAlzheimerâS Disease BiomarkerAlzheimer Disease ScreeningBiometryAffectScreening
Grant awards (4)
Examining the influence of sociodemographic and medical factors on plasma p-tau217 performance in at-risk populations$184,288
K23 · FY2025 · AG · contact PI
Examining the influence of sociodemographic and medical factors on plasma p-tau217 performance in diverse communities$185,012
K23 · FY2024 · AG · contact PI
Plasma Phosphorylated-Tau, Neurodegeneration, and Clinical Outcomes-Childcare Supplement$2,500
F32 · FY2023 · AG · contact PI
Plasma Phosphorylated-Tau, Neurodegeneration, and Clinical Outcomes$67,174
F32 · FY2022 · AG · contact PI